Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Retinal Vein Occlusion With Macular Edema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT06708637
What this trial is testing

Ocular Safety and Usability Study for FYB203 PFS

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular Edema+2 more
Formycon AG 30
Post-approval studies (Phase 4)UnknownNCT02522897
What this trial is testing

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
PD. Dr. med. Armin Wolf 60
Large-scale testing (Phase 3)UnknownNCT03353324
What this trial is testing

Comparison of Therapeutic Effects Between Intravitreal Injection of Bevacizumab With Intravitreal Injection of Bevacizumab and Targeted Laser Photocoagulation of Non Perfused Areas of Retina in Patients With Acute Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion With Macular Edema
Shahid Beheshti University of Medical Sciences 74
Not applicableStudy completedNCT02181530
What this trial is testing

Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 43
Testing effectiveness (Phase 2)Study completedNCT04667897
What this trial is testing

601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Post-approval studies (Phase 4)UnknownNCT03892434
What this trial is testing

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 40
Not applicableUnknownNCT02169648
What this trial is testing

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein OcclusionCentral Retinal Vein Occlusion
Tokyo Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07205887
What this trial is testing

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

Who this might be right for
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. 160
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Large-scale testing (Phase 3)Active Not RecruitingNCT04444492
What this trial is testing

Combination of Ranibizumab and Targeted Laser Photocoagulation

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
University of Giessen 88
Testing effectiveness (Phase 2)Study completedNCT00407355
What this trial is testing

Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Peter A Campochiaro, MD 40
Large-scale testing (Phase 3)Study completedNCT04516278
What this trial is testing

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 197
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Large-scale testing (Phase 3)Ended earlyNCT03810313
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 493
Not applicableUnknownNCT04140448
What this trial is testing

Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Renmin Hospital of Wuhan University 60
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Not applicableStudy completedNCT03054766
What this trial is testing

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein OcclusionRanibizumabLaser Photocoagulation
Beijing Hospital 80
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT04085341
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Diabetic Macular EdemaRetina Vein Occlusion
Graybug Vision 21
Testing effectiveness (Phase 2)Study completedNCT01662518
What this trial is testing

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Centro de Pesquisa Rubens Siqueira 10
Next Page